Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06891443 |
| Consolidated Lead Sponsor | Laboratoires Thea |
| Therapeutic Condition Cohort | Ophthalmology and Sensory |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 32 participants (ESTIMATED) |
| Registered Start Date | 2025-06-04 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| UCSF Medical Center and Helen Diller Cancer Center | San Francisco, CA | Open Hospital Dossier -> |
| University of Iowa | Iowa City, IA | Open Hospital Dossier -> |
| University of Pennsylvania Abramson Cancer Center | Philadelphia, PA | Open Hospital Dossier -> |
| University of Alberta | Edmonton, Canada | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Ophthalmology and Sensory Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.